Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation
- 23 October 2017
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 34 (3) , 252-255
Abstract
Although the classification and management of ovarian hyperstimulation syndrome (OHSS) are well described in the literature, little attention has been given to modalities that aim to prevent its occurrence. In this retrospective study, we sought to investigate whether a combination of modalities in addition to GnRH agonist triggering in GnRH antagonist cycles could result in better prevention of OHSS. The study included 170 hyperresponder patients who were stimulated with GnRH antagonist protocol and were triggered with GnRH agonist for final oocyte maturation. Freeze all embryos was performed in all patients. The intervention group included treatment with dopamine agonist and restarting the GnRH antagonist. Of the 170 patients included, 63 were included in the intervention group. Compared to no intervention, women in the intervention group were more likely to have: menses within 7 days of the oocyte retrieval, smaller ovarian diameter, the absence of free pelvic fluid, less hemoconcentration and higher serum sodium levels. It can be concluded that combining other modalities in addition to triggering with GnRH agonist in GnRH antagonist cycles, results in targeting several pathways that lead to OHSS and result in rapid resolution of signs of ovarian hyperstimulation.Keywords
This publication has 25 references indexed in Scilit:
- Risk factors for ovarian hyperstimulation syndrome: relevance of the number of follicles, serum estradiol levels and the number of oocytes collectedHuman Reproduction, 2013
- GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patientsHuman Reproduction, 2013
- Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCGHuman Reproduction, 2013
- Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta‐analysis of randomised controlled trialsBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort studyReproductive Biology and Endocrinology, 2012
- Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcomeFertility and Sterility, 2010
- Low-dose aspirin therapy to prevent ovarian hyperstimulation syndromeFertility and Sterility, 2010
- Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilizationAmerican Journal of Health-System Pharmacy, 2008
- Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized studyFertility and Sterility, 2007
- Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell culturesFertility and Sterility, 2006